Friday, 26 November 2021

Merck Says Its Covid Pill Is Less Effective in a Final Analysis

The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.

from NYT > Top Stories https://ift.tt/3p2BTlU
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)